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RIASSUNTO 
 
L’asma è una malattia complessa delle vie aeree, caratterizzata da ostruzione reversibile 
del flusso respiratorio e da ipersensibilità bronchiale.  L’asma viene definita come una 
malattia genetica con vari fenotipi, attribuiti ad un interazione tra fattori ambientali e geni 
multipli. 
In una precedente scansione genomica per asma, condotta su 123 famiglie del nord est 
Italia caratterizzate per asma clinica, rinite, IgE seriche totali elevate, positività al test di 
cutireazione per aeroallergeni comuni e iperreattività bronchiale alla metacolina, è stata 
osservata la presenza di linkage tra la regione cromosomica 13q14 e livelli elevati di IgE 
seriche totali. 
Due studi recentemente riportati in letteratura, Zhang et al., 2003, e Jang et al., 2005, 
condotti nei geni contenuti in questa regione, hanno identificato la presenza di 
associazione del gene PHF11 con IgE elevate e dermatite atopica, rispettivamente. 
Lo scopo di questo lavoro era di sviluppare una tecnica di genotipizzazione multipla e di 
effettuare uno studio di associazione del gene PHF11 nelle 23 famiglie (per un totale di 
144 individui) che avevano mostrato linkage positivo per IgE seriche totali elevate.   
Sono state analizzate 7 SNP all’interno del gene PHF11, riportate in letteratura in 
associazione ad IgE elevate:  rs2247119, nell’introne 3; rs2274276, nell’introne 4; 
rs2031532, nell’esone 2; rs1046295, nella zona 3’UTR; 185752b5_2, nell’introne 9; 
185306b7_1, nell’introne 1; e 185752b4_2, nell’introne 5.  Le prime quattro sono state 
riportate associate anche a dermatite atopica. I 7 polimorfismi sono stati prima confermati 
con alcuni controlli della stessa popolazione mediante sequenziamento o restrizione 
enzimatica.  Le SNP rs2247119, e rs2274276 sono state analizzate tramite PCR e 
restrizione enzimatica con gli enzimi Fnu4 HI e Nsp I, rispettivamente.  Per le altre 5 SNP 
è stato sviluppato un metodo di genotipizzazione multipla mediante la tecnica del ddNTP 
Primer Extension, utilizzando lo SNaPshot Multiplex kit (Applied Biosystems) analizzata 
dal sequenziatore ad elettroforesi capillare ABI PRISM 310 con il programma Genescan.   
L’analisi statistica mediante il TDT test con il programma Merlin ha confermato la 
presenza di linkage tra la regione cromosomica studiata ed IgE seriche totali elevate, ma 
non ha mostrato presenza di associazione tra le SNP analizzate ed IgE in asma allergica.  
Nessuna associazione è stata identificata con altri fenotipi.  L’associazione potrebbe 
quindi essere dovuta nella nostra popolazione ad altri polimorfismi presenti in questo gene 
o in geni vicini.   
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SUMMARY 
 
Asthma is a disease of the lungs characterized by reversible airway obstruction and 
bronchial hyper-reactivity and is associated with pulmonary inflammation.  Asthma has an 
important genetic component but no clear pattern of inheritance;  its phenotypes, including 
bronchial hyper-responsiveness (BHR), atopy, and increased IgE, result from the 
interaction of multiple gene variants, each having a modest effect, and the environment.  
In a previous genomic screen for asthma, conducted on 123 families from north east Italy, 
characterized for clinical asthma, rhinitis, elevated total serum IgE, positive Skin Prick 
Test, and bronchial hyper-responsiveness (BHR) to methacholine, it has been observed 
the presence of linkage between region 13q14 and elevated total serum IgE. 
Two studies, recently reported in literature, Zhang et al., 2003, and Jang et al., 2005, 
identified an association of the PHF11 gene with elevated IgE and atopic dermatitis, 
respectively. 
The aim of this study was to develop a multiple genotyping technique and to perform an 
association study of the PHF11 gene in the 23 families, for a total of 144 individuals, 
which demonstrated positive linkage to elevated total serum IgE. 
7 SNPs have been analyzed in the PHF11 gene, reported in literature associated with 
elevated IgE:  rs2247119, in intron 3; rs2274276, in intron 4; rs2031532, in intron 2; 
rs1046295, in the 3’UTR zone; 185752b5_2, in intron 9; 185306b7_1, in intron 1; and 
185752b4_2, in intron 5.  The first four SNPs have also been associated to atopic 
dermatitis. 
The 7 polymorphisms have been first validated with 15 control samples of the same 
population by sequencing and enzymatic restriction.  The SNPs rs2247119, and 
rs2274276 have been analyzed through PCR and enzymatic restriction with the enzymes 
Fnu4 HI and Nsp I, respectively.  The other 5 SNPs have been analyzed in multiplex with 
the ddNTP Primer Extension technique, utilizing the SNaPshot Multiplex kit (Applied 
Biosystems) with the ABI PRISM 310 Genetic Analyzer using the Genescan program.   
The genotyped SNPs have been analyzed through TDT Test with the Merlin program.  
This analysis confirmed the presence of linkage between region 13q14 and IgE, but a 
presence of association between the analyzed SNPs and IgE in allergic asthma was not 
observed.  No association was identified with other asthma related phenotypes.   
The analysis suggests that other polymorphisms or genes may be involved, and can 
interfere with the association.  It may be appropriate to further extend the analyzed region 
to other neighbouring regions, which demonstrated positive linkage to asthma and related 
phenotypes. 
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1.1  ASTHMA 
 
The term asthma derives from the Greek word “άσµα”, which means “heavy 
breath.”  Hippocrates, acknowledged as the “father of medicine” around 400 A.C., 
was the first to address asthma and to denominate it as a disorder (Trabalzini, 
2005). 
In the early 1900, asthma was considered a Mendelian inheritance disorder, where 
a single gene is responsible for a defect or an abnormality.  It was only in 1954 
that Tips proposed a polygenetic mode of asthma inheritance (Tips, 1954).  This 
theory was further developed in 1967 by Leigh and Morley, who suggested that 
asthma is a multifactorial trait in which multiple gene loci interact with one or more 
external factors (Bias et al., 1978 and Marsh et al., 1992).   
The prevalence of asthma has increased in the past two to three decades in both 
children and young adults.  The reasons for this increase are still poorly 
understood.  There has been speculation about the importance of changes in the 
indoor or outdoor environment, in the climate and in the lifestyles.    
Today, asthma has reached epidemic proportions, affecting, globally, 300 million 
people of all ages and all ethnic backgrounds, touching annually health care costs 
of approximately 30 billion dollars (Selgrade et al., 2006) 
 
 
1.2 ASTHMA CLASSIFICATION 
 
The American Thoracic Society and the National Asthma Education and 
Prevention Program (NAEPP) define asthma as a chronic inflammatory disorder of 
airways characterized by reversible obstruction, bronchial hyper-reactivity and 
recurrent episodes of wheezing, chest tightness, or coughing. (Figure 1.1)  Airway 
inflammation, smooth muscle contraction, epithelial sloughing, mucous hyper-
secretion, bronchial hyper-responsiveness (BHR), and mucosal edema, are all 
responsible for the underlying pathophysiology of asthma (Lenchner et al., 2004).   
Asthma can be classified according to its severity as atopic or extrinsic asthma, 
nonallergic or intrinsic asthma, mixed asthma, exercise-induced asthma, cough 
variant asthma, aspirin-induced asthma, and fatal asthma (Lenchner et al., 2004).   
Allergic asthma, found in 60 to 75% asthma patients (McFadden et al.,1992 and 
Abbas et al., 1994), is caused in part by a predisposition to atopy, which is 
indicated with elevated levels of total serum IgE and hypersensitivity to certain 
______________________________________________________________ Introduction 
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antigens called allergens.  Atopic individuals produce abnormally high levels of IgE 
antibody in response to these allegens, express more high affinity IgE receptors 
than normal individuals, and have more of these receptors occupied by IgE 
(Corrigan et al.,1992 and Abbas et al., 1994).   
Non-allergic or instrinsic asthma does not have an allergic cause.  It usually 
develops later on in life, with a 10-33% incidence.  It is associated with respiratory 
or sinus infections, pollution, and tobacco smoke, but it has also some family 
disposition. 
Mixed asthma is a combination of allergic and nonallergic asthma, in which the 
patient can have asthma symptoms but no positive skin test for allergens. 
Exercise-induced asthma may occur in cold and dry environments, and it can be 
present in patients with persistent or mild asthma. 
Cough variant asthma presents, as a primary symptom, cough, and it can occur 
after respiratory infections, exercise, allergic or non-specific triggers.  
Aspirin-induced asthma may be triggered within minutes or up to 3 hours after 
intake of an aspirin or other nonsteroidal anti-inflammatory medications (Lenchner 
et al., 2004) 
The study of this thesis is referring to allergic asthma.   
 
 
 
Figure 1.1  Image showing the differences in the lung structure of a normal and of an  
        asthmatic individual. 
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1.3  ASTHMA RISKS 
Allergic asthma is a very complex disorder.  It usually manifests itself with the 
rising of allergies.  Asthma is characterized by an elevated IgE production in 
response to common aeroallergens, such as pollen, dust mites, indoor and 
outdoor mold, animal dander, and cockroaches.  Also tobacco smoke, indoor and 
outdoor air pollution, strong profumes, cleaning sprays, and chemical fumes can 
play an important role in triggering asthma as well as food preservative, milk, 
eggs, and shellfish.  
An asthma episode is  due to a sensitization to allergens.  Once this event has 
occurred, all the successive exposures to that allergen will elicit a hypersensitive 
immune response.  Sensitization to allergens may occur as early as in the 
developing fetus, resulting in allergens passing directly crossing the placenta or 
via maternal cells, carrying allergens into the fetal bloodstream (Holgate et al, 
1995). 
Allergen exposure in early life has been linked to allergic sensitization and later 
onset of asthma (Selgrade et al., 2006).  Asthma affects for the majority children 
under 10 years of age.  It has been observed that in the first decade of life, asthma 
is more frequent in males, with a ratio males to females 2.5:1, the ratio becomes 
about equal during adolescence, and in adults, female asthmatic patients 
outnumber males (Selgrade et al., 2006).  
Allergic asthma is identified by skin prick test (STP) or by measurement of specific 
serum IgE titers against allergens or elevation of the total serum IgE 
concentration. 
Because of its complexity, it has been very challenging to find a definite cure for 
asthma.  The drugs used currently in the treatment are bronchodilators, 
corticosteroids, mediator antagonists, cytokine modulators, and specific anti-
allergic drugs that inhibits IgE production.  
Recently, it has been reported in the Seattle Puget Sound Business Journal, a 
new experimental cure for patients with moderate to severe asthma, called 
bronchial thermoplasty.  Bronchial thermoplasty uses radiofrequency to reduce 
smooth muscles in the bronchial airways, bringing to the patient less frequent and 
severe asthma symptoms (MacNaughton, 2006).   
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TRIGGER FACTOR 
 
 
AIRWAY INFLAMMATION 
 
           
MUCUS PRODUCTION               AIRWAY       SWOLLEN BRONCHIAL  
     MUSCLE TIGHTENING  MEMBRANES 
             
 
    NARROW  BREATHING  PASSAGES 
             
 
   WHEEZING, COUGH, SHORTNESS OF BREATH 
 
Figure 1.2  The diagram summarizes the events that lead to an asthma attack.  A trigger  
        factor as tobacco smoke or respiratory infections, initiates airway  
        inflammation, which produces bronchial membrane swelling, muscle                       
        tightening, and mucus production.  These events cause a narrowing  
        of the passages initiating cough, wheezing, and shortness of breath. 
 
 
 
1.4  PATHOGENESIS 
Upon initial exposure to an allergen, CD4+ T helper cells begin to differentiate into 
Th1 or Th2 cells.  Th1 cells mediate phagocytic immune responses to intracellular 
microbes, while Th2 cells mediate IgE-dependent immune responses to allergens.  
In addition to mediating immune responses, each of these T cell subsets produces 
cytokines that inhibit the proliferation of the other subset.  Th1 cells produce high 
IFN- γ levels, which inhibits Th2 cell growth.  Th2 cells produce IL-10, which 
inhibits Th1 cell growth, and IL-4, which promotes IgE production.  In response to 
an antigen, these cell populations will competitively grow, and one subset will 
become dominant and differentiate into memory cells, that will determine future  
responses to the allergen.  When the Th1 subset is dominant, the individual is able 
to inhibit IgE production, which effectively protects against atopy.  This IgE  
______________________________________________________________ Introduction 
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suppression may also be enhanced by allergen-specific CD+8 T cells that secrete 
IFN- γ.  However, if the Th2 subset is dominant, IgE production is increased and  
the individual becomes atopic to the allergen  (Holt, 1995, and Corrigan et al., 
1992).   
Once sensitization to an allergen has occurred, all the successive exposures to 
that allergen will elicit a hypersensitive immune response, as seen in asthma.  The 
immune response begins with the binding, processing, and presentation of the 
allergen by dendritic cells in the lungs.  In non asthmatic individuals, the bronchial 
epithelium provides a protective barrier against inhaled allergens that prevents 
these particles from reaching the antigen presenting dendritic cells beneath the 
epithelial layer.  In asthmatic patients, however, it has been demonstrated that the 
bronchial epithelium is unusually permeable to certain allergens, allowing access 
to the subepithelial dendritic cells.  
The initial response to allergen exposure is called the early phase asthmatic 
response (occurring 4 to 6 minutes after exposure), and is mediated by the IgE 
antibody network.  Upon activation by allergen, the Th2 cell secretes IL-4 which 
induces the isotype-switching and allergen-specific IgE production by B 
lymphocytes.  IgE binds to the allergen, and this complex in turn binds to certain 
high affinity IgE receptors (Sutton et al., 1993). 
After binding to the mast cell, these allergen-IgE complexes, cross-linked with 
each other, stimulate the mast cell to release its intracellular granules.  Such 
degranulation is also stimulated by histamine releasing factors secreted by T cells 
(Wilson et al., 1994).   
Mast cell granule products, including histamine, leukotrienes, tryptase, 
prostaglandin, and platelet-activating factor, are major contributors to asthma 
clinical manifestation.  These products produce the immediate 
bronchoconstruction, vasodilation, mucus secretin, and tissue destruction that 
characterize an early phase asthmatic response.   
The second pathway in an asthmatic immune response is the direct Th2 cell-
mediated eosinophil recruitment and lungs’ infiltration in the late phase  
asthmatic response.  This recruitment phase is begun by IgE-activated mast cells 
and is greatly enhanced by the Th2 cells’ arrival to the allergen exposure site 
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(Holgate et al., 1995, and Makino et al. 1995).  In addition to IL-4, Th2 cells 
secrete IL-3, IL-5, and GM-CSF, all of which result in the migration of  
eosinophils to the region of allergen exposure.  As seen in mast cells, these 
cytokines promote the expression of certain adhesion molecules by local 
endothelial cells to increase eosinophil binding, and also function in eosinophil 
activation, differentiation, and survival (Drazen et al., 1996, Redington et al., 1995, 
and Corrigan et al., 1992).  Eosinophils recruited to the site of allergen exposure 
become the major effector cells of the late phase asthmatic response.  The most 
significant eosinophil response result in asthma, is the bronchial epithelium 
damage and death, which is directly correlated with increased airway hyper-
responsiveness. 
 
 
 
Figure 1.3 Principal mechanisms involved in the pathogenesis of allergic asthma. Antigen  
                   recognition from antigen presenting cells (APC) causes limphocytes activation  
       and differentiation into TH2 cells,  The activated cell stimulate B cells to  
       produce IgE antibodies, in response to IL-4, and to a lower extend to IL-13      
       and IL-9.  IgE stimulate mast cells granulation, and the release of histamine,  
       which causes bronchospasm.  Mast cells also release chemotactic factors for  
       eosinophils.  TH2 cell cause epithelial cells mucus production. 
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1.5   ALLERGIC ASTHMA GENETICS 
 
Multifactorial diseases are complex genetic disorders with variable phenotypes, 
largely attributed to the interaction of the environment and multiple genes, each 
potentially having small effects (Hakonarson et al., 2001).   
In the case of asthma, multiple environmental factors are known to play an 
important role in triggering and modulating asthma responses, whereas the 
genetic components that underline the susceptibility to react to these 
environmental factors still remain largely unknown.  
In several studies, it has been reported that asthma has a higher frequency in first 
degree relatives than in non-related individuals.  In fact, it has been seen that 
asthma phenotypes are present for 25% in children of asthmatic parents 
(Panhuysen et al., 1998).  Also in twins studies, it has been observed that there is 
a greatest incidence of asthma and its phenotypes, in monozygotic twins 
comparing to dizygotic ones, given that monozygotic share 100% of the genes 
while dizygotic about 50%, as normal siblings (Panhuysen et al., 1998). 
Moreover, an Australian twins study, conducted on 3800 twin-pair , showed a clear 
evidence of  a genetic component in the development of asthma (Duffy et al., 
1990).   
Litonjua et al., in fact, has shown evidence for preferential inheritance of early-
childhood asthma through the maternal line; while the development of asthma later 
in life have been observed to be preferentially inherited from the paternal line.   
However, up until now, it has not been possible to identify a precise inheritance 
model for asthma because of its complex genetic factors’ interaction, that confer 
with familiar disposition, and with environmental factors.  It is likely that asthma 
inheritance model is polygenic, involving multiple genes, each one having a small 
distinct effect, and environmental factors, such as allergens, pollution and 
respiratory infections, which could act as causing elements in genetic susceptible 
individuals (Anderson et al., 1999; Cookson, 2002; Wills-Karp and Ewart, 2004). 
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IDENTIFICATION METHODS FOR ASTHMA’S SUSCEPTIBILITY GENES 
 
Complex diseases are common and they represent the larger cause of morbidity in 
developed countries.  The identification of genetic involved agents, represent 
today one of the principal objectives of genetic research, and will allow a  better 
understanding of the pathogenetic mechanisms, new pathologies development, 
prevention strategies and diagnostic methods (King et al., 2002). 
The strategies used to identify susceptibility genes for asthma include linkage 
analysis and association studies.  
The linkage analysis takes into examination affected individuals’ families and 
identifies the region that could contain the susceptible gene, showing a marker 
cosegregation with the disease.  It can be carried out by the analysis of markers 
distributed all over the genome, known as a genome-wide screening.  The 
genomic screenings have had an excellent success on Mendelian diseases’ gene 
mapping, but they have been much more difficult to use for multifactorial diseases, 
despite the genotyping methods and statistical analysis, due to their complexity. 
Linkage analysis can also be performed with the candidate gene, of which it is 
hypothesized the involvement of the disease (Altmüller et al., 2001; Sengler et al., 
2001). 
 
An association study, on the other hand, compares the relative frequencies of 
gene polymorphisms in unrelated affected individuals and unaffected controls;  the 
presence of a significant difference indicates association between the allele and 
the disease (Gao et al., 2004).  Candidate genes are chosen on the basis of 
functional or positional correlation to the disease. 
A positive association can signify that the allele is the disease causing factor, 
since it influences the gene function, modifying for example the transcriptional 
properties, the splicing sites or the amino acidic sequence.  But a positive 
association can also indicate that the allele is in linkage disequilibrium (LD) with 
the real locus of the disease (Hoffjan et al., 2003). 
Genetic markers used for linkage and association studies are polymorphic sites. 
Single nucleotide polymorphisms (SNP) are the markers mostly used in 
association studies.  SNPs are biallelic, therefore less informative than other 
markers, such as microsatellites, but they are more numerous, usually 1every  
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1000 nucleotides, widely spread along the whole genome, and more easily 
managed for multiple genotyping techniques at advanced levels (Schork et al., 
2000; Strachan & Read, 2004). 
SNPs are arranged in LD blocks allowing the definition of chromosomal region by 
the use of a single SNP inside the LD block (tagged SNP).   
 
 
1.6  LOCALIZATION TECNIQUES 
The complexity of asthma genetics implies the analysis of a wide number of 
polymorphic markers.  The susceptibility genes’ research uses various techniques, 
which are divided into two major groups:  the first group includes techniques that 
identify new sequence variation of the candidate gene, such as Single Strand 
Conformation Polymorphisms (SSCP), Denaturing Gradient Gel Electrophoresis 
(DGGE), and Denaturing High-Performance Liquid Chromatography (DHPLC).  
The second group includes techniques that analyze already known variations, 
such as RFLP Analysis, Reverse Dot Blot (RDB), Oligonucleotide Ligation Assay 
(OLA), Minisequencing or ddNTP Primer Extension, and techniques based upon 
DNA chips.  Sequencing can be used for both groups (King et al.. 2002;  Strachan 
& Read, 2004). 
 
▫ The SSCP technique identifies the presence of a sequence variation in a 
Single Strand DNA molecule through alteration in eletrophoretic mobility in 
non-denaturing gel. 
 
▫ The DGGE is a technique that allows to identify any sequence variation in 
Double Strand DNA molecules, on the basis of difference in Tm and gel 
eletrophoretic mobility in denaturing conditions of hetero or homoduplex 
molecules.  
 
▫ DHPLC is a capillary chromatographic technique based on the same 
principles of DGGE. 
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▫ The polymorphisms length analysis of the restriction fragments (RFLP), is 
based upon the property of  this polymorphism to eliminate or create a 
natural restriction site or an appropriate designed PCR primer (Gasparini et 
al,. 1992). 
 
▫ The Reverse Dot Blot (RDB) technique is based upon the DNA 
hybridization with specific allele oligonucleotide primers.   
 
▫ The OLA (Oligonucleotide Ligation Assay), is based upon the use of two 
oligonucletidic allele specific primers, which hybridize DNA in the sequence 
next to the variation to be analyzed, and the DNA ligase, which covalently 
binds to a third primer only in the presence of a perfect match.  The analysis 
method is performed  with automatic DNA sequencers. 
 
▫ The minisequencing or ddNTP Primer Extension is based upon the 
ddTerminators’ chemistry, and results from a Single di-deossinucletide-
trifosphate ddNTP primer extension.  The analysis method uses automatic 
DNA sequencers, or other technologies, such as MALDI-TOF Mass 
spectroscopy (Ross et al., 1998). 
 
▫ DNA chip are based upon minisequencing or allele specific primer 
hybridization, described above, but with the use of automatic instruments.  
They are obtained, fixing oligonucletides on glass supports, through 
photolithography process.  The oligonucleotides are marked with 
fluorescence, and they are analyzed with laser instruments (Carella et al., 
2003). 
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1.7  IDENTIFIED REGIONS ASSOCIATED TO ASTHMA 
A genome wide screen consists of a systematic search for genetic linkage to a 
disease across all human chromosomes.  Eleven full genome screens have been 
reported for asthma and its associated phenotypes, and others have been carried 
out in industry (Cookson, 2002).  Several of these screens have been performed in  
distinct European populations, such as German (Wjst et al., 1999), French (Dizier 
et al., 2000), Finnish (Laitinen et al., 2001), Icelandic (Hakonarson et al., 2002), 
Dutch (Koppelman et al., 2002), and Danish (Haagerup et al., 2002).   
The replicated regions reported, for the asthma phenotype, have been on 1p, 2q, 
4q, 5q, 6p, 12q, 13q, 14q, 19q, and 21q; for total serum IgE sites on 2q, 3q, 5q, 
6p, 7q, 12q, 13q; atopy on chromosomes 3q, 4q, 6p, 11q, and 17q; and eosinophil 
counts on 15q (Hoffjan et al., 2002) Table 1.1 
 
The loci most consistently identified by these screen will be further described 
underneath: 
▪  1q32  In this region, some studies have shown that Adenosine A1 
receptor (A1AR) is a signalling molecule that plays a role in the regulation of 
inflammation by promoting IL-4 and IL-13 production, and stimulates mucus 
production by the regulation of CLCA1 (McNamara et al., 2004)  
 
▪  2q14  In this region, two independent groups recently reported two 
different candidate gene, IL-R1N and DPP10, both mapping in the region of 
the IL-1 cluster.  DPP10, encoding a homolog of dipeptidyl peptidases 
(DPPs), shares features with members of the S9B family of DPP serine 
proteases, which includes DPP4, a widely expressed enzyme that plays a 
central role in chemokine processing as part of the innate immune response 
(Allen et al., 2003; Gao et al., 2004). 
 
▪  5q34  This region has been linked to total serum IgE concentrations, to 
eosinophil levels and to schistosomiasis resistance.  The region contains 
several genes that modulate atopic responses, including IL-4, IL-13, IL-5, 
CD14, and granulocyte macrophage-colony stimulating factor (GM-CSF) 
(Cookson, 2002).  
Table 1.1 Summary of asthma related genes and their chromosome location (Malerba et  
     al., 2005) 
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▪  6p21  The human major histocompatibility (MHC) gene and other genes 
that play a role in regulating the immune system are mapped on 
chromosome 6p21 (Shiina et al., 2004).  This region has shown strong 
linkage to atopic phenotype and asthma, and it is considered a major locus 
influencing allergic diseases (Cookson 2002;  Hakonarson and Wjst 2001;  
Moffat et al., 2003).  Other studies reported also association with the TFN-α 
(Shin et al., 2004).  The susceptibility for asthma linked to this region is very 
complex and it may be influenced by maternal factors. 
 
▪  7p14-15  This region contains the GPRA gene, a G-protein-coupled 
receptor for asthma susceptibility, which is associated with high levels of 
IgE, clinical asthma, and atopy (Laitinen et al., 2004). 
 
▪  9p21  In Hutteries families, it has been reported an evidence of linkage 
with a short tandem repeat polymorphism (STRP) within the type I 
interferon (IFN) gene cluster on chromosome 9p21(Chan et al., 2006).  This 
region has shown linkage to IgE and Skin Prick Test. 
 
▪  11q13  This region was first linked to atopy.  It contains the β-chain of the 
high-affinity receptor for IgE (FcєRI-β).  The FcєRI-β acts as the allergic 
trigger on mast cells and other types of cells; it is central to allergic 
response.  The β-chain is not essential for FcєRI-β function, but it both 
stabilizes the surface expression of the receptor and acts as an amplifying 
element within it.  Any variation in the level of the β-chain expression may 
therefore modify receptor function (Cookson, 2002). 
 
▪  12q13-26  In the long arm of the chromosome 12 are located many 
different  candidate genes for allergic asthma and its phenotypes.  STAT6 
(Signal transducer and activator of transcription 6 gene), involved in the 
initiation of signals from Th2 cells, through IL-4 and IL-13 receptors;  IFN-γ 
gene, and the nitric oxide synthase 1 gene (NOS1) (Malcolm, 2005). 
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▪  13q14  This region was identified as associated to high levels of total 
serum IgE and atopic dermatitis.  Chromosome 13 will be further described 
in the next chapter since chosen for the analysis of this study.  
 
▪  14q  In this region, recently, Mansur et al. reported linkage and 
association of the D14S63 marker with total serum IgE levels in asthmatic 
families (Mansur et al., 2004).  The marker D14S63 is located 16 Mb from 
the prostaglandin D2 receptor  (DP) gene (PTDGR).  The PTDGR gene is 
present on mast cells and eosinophils, which generate the effector 
molecules of the asthmatic diathesis (Kabashima and Narumiya 2003). 
 
▪  17q  On chromosome 17, the predominant eosinophil chemoattractant is 
the gene for eotaxin (SCYA11), which is involved in allergic inflammation.  
SNPs, in its promoter region, have been found in many studies to be 
associated with asthma, eosinophil count, and lung function (Hoffjan et al., 
2003).  Shin et al. confirmed its association with asthma and total serum IgE 
(Shin et al.,2004). 
 
▪  20p13  In this region, it is located ADAM33 gene, associated with asthma 
and bronchial hyper-reactivity.  It codes for a disintegrin and 
metalloproteinase that triggers intracellular and extracellular signalling by 
protein shedding (Werner et al., 2004).  Expression analysis confirmed that 
ADAM33 is expressed in multiple tissues, such as the lung and lymph node.  
ADAM33 variants may directly impact lung architecture and function.  On 
the other hand, since ADAM proteins (ADAM10 and ADAM17) appear to 
interact with inflammatory cytokines, it has been hypothesized that ADAM33 
may also have important cytokine-stimulating effects, contributing to asthma 
susceptibility (Weiss et al., 2004). 
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1.8  CHROMOSOME 13 
 
 
Figure 1.4  Chromosome 13 
 
Chromosome 13 has been subject of many studies throughout the years. 
In 1985 was reported by Eiberg et al., a first linkage of total serum IgE to the 
esterase D protein on chromosome 13q14 (Eiberg et al., 1985). 
Association, on a segment of chromosome 13q14 that spanned 7.5cM, was then 
confirmed in a set of Australian families  After this initial findings, investigators 
genotyped additional microsatellite markers within the peak region, and assessed 
each marker for association with total serum IgE.  A strong association was 
detected with a novel marker USA24G1 (Anderson et al., 2002).  After creating a 
dense SNP map over 1.5Mb region around USAT24G1 marker,  Anderson et al. 
genotyped 54 common variants in 80 nuclear families.  Significant association, 
extending over 100 kb region spanning to linkage disequilibrium blocks, identified 
PHF11 gene as a putative candidate gene (Zhang et al., 2003). 
 
PHF11 gene 
The PHF11 gene, PDH Finger Protein 11, encodes NY-REN-34, a protein that was 
first described in patients with renal cell carcinoma (Scanlan et al., 1999) and its 
transcripts are highly represented in stomach, tonsil and B cells (Zhang et al., 
2003) 
The gene product contains two PHD (plant homeodomain) zinc finger domains, 
which suggest involvement in chromatin-mediated transcriptional regulation 
(Aasland et al., 1995).   
PHD fingers protein normally posses two Zn²+  coordinating groups that contain 
cysteine and histidine residues.  The N-terminal (5’) finger of the PHF11 finger 
pair, however, lacks one of the two coordinating groups.  The arrangement of PHD 
finger in PHF11 is a characteristic of human proteins, such as ALL-1 and AF10,  
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whose genes are fused in some cases of acute lymphoblastic leukemia (Angioni et  
al., 1998).  Analogy to AF10 and all PHD fingers suggests that the PHF11 PHD 
finger pair has a role in homodimerization, and protein binding or both.   
The PHF11 gene contains 10 exons (Figure 1.5).  PHF11 is flanked by SETDB2 
and RCBTB1.  SETDB2 is 4 kb proximal to PHF11 and it is transcribed in the 
same direction.  It is a histone H3 methyltransferase, as it contains both active site 
and flanking cysteine residues, that are important for catalytic activity (Walker et 
al., 1996).  
The close position of SETDB2 and PHF11 suggested that the two genes might be 
coordinately expressed (Zhang et al., 2003). 
A study performed in European descent population from Busselton in Western 
Australia, has demonstrated association of this gene with elevated IgE (Zhang et 
al., 2003) 
 
 
Figure 1.5  PHF11 gene   
 
 
1.9  REGION INVESTIGATED  
In this study, the region 13q14, located on the PHF11 gene, was investigated.  
This region was selected for its strong linkage to levels of total serum IgE resulting 
from a previous genomic screening. 
The previous linkage analysis was conducted in families collected from the 
Pediatrics Section of the Mother and Child, and Biology-Genetic Department of the 
University of Verona (professor Boner), and from the Bolzano Hospital (Dr. 
Pescollderungg).  The families were selected for the presence of at least 1 
affected child with allergic asthma.   
 
 49000  48990 
 48980 
 48970 
 Kb 
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The sample included both nuclear families (parents and children), and more 
extended families, formed by dependent nuclear families.  In particular, the sample 
was composed by 108 nuclear families, 8 families with 2 nuclei, 4 with 3, 1 with 4, 
1 with 5, and 1 with 9 nuclei for a total of 154 nuclear families. 
The studied individuals were characterized for the following phenotypes:  clinical 
asthma, rhinitis, bronchial hyper-reactivity to metacholine (BHR), elevated total 
serum IgE, positive Skin Prick Test to common allergens (SPT), positive test to 
common allergens, such as dust mites, and atopy.   
Families showing positive linkage for elevated total serum IgE with region 13q14, 
were selected for the present study. 
 
 
 
 
 
Figure 1.6  Location of the PHF11 gene and the 7 analyzed SNPs 
Chromosome13 
     PHF11 gene 
     SETDB2 
  rs2031532 
185306b7_1 
 rs2247119 
   
  rs2274276 
  185752b4_2   
 
 
185752b5_2 
rs1046295  
  NT_024524 
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2.  AIM OF THE STUDY 
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The aim of this study was to perform an association analysis of the PHF11 gene 
Single Nucleotide Polymorphisms, in Italian families with allergic asthma, which 
previously demonstrated positive linkage to increased levels of total serum IgE. 
This study also included the development of an efficient multiple genotyping 
technique. 
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3.  MATERIALS AND METHODS 
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3.1 PATIENTS 
 
The study of this thesis, was conducted on 23 asthmatic families (144 individuals) 
from North East Italy.  The selected individuals, collected from the University of 
Verona Pediatrics Clinic, belonged to a bigger sample of patients, analyzed in a 
previous linkage study on asthma.  All the enrolled subjects were characterized for 
the following phenotypes:  clinical asthma, rhinitis, bronchial hyper-reactivity to 
metacholine (BHR), elevated total serum IgE, positive Skin Prick Test to common 
allergens (SPT), and atopy. 
The families, selected for the study described in this thesis, showed positive 
linkage between the region 13q14 and elevated total serum IgE, in a previous wide 
genome screen (data not yet published). 
The diagnosis for clinical asthma and rhinitis is based upon family and personal 
medical history, physical exam, lung function tests, and the completion of a survey 
prepared in line with the standards of the American Thoracic Society and the 
European Respiratory Society.   
Bronchial hyper-reactivity to methacholine (BHR) is determined by progressive 
intake of increased doses of methacholine, and the response is measured by a 
spirometer.  All the healthy and asthmatic individuals, respond to methacholine 
with a bronchial-construction, but they differ in the doses (low dose for the 
asthmatic, high dose for the healthy patients).  The response to bronchial-
construction is measured by FEV1 (force expiratory volume in one second).  When 
the methacholine response causes a 20% FEV1 reduction (PC20), compared to 
the normal value, the patient is said to be positive.  There are two PC20 values:  
10 mg/ml (BHR10 constructed value), and 25 mg/ml (BHR25 standard value). 
Patients are considered positive to Skin Prick Test if reactive to at least one of the 
tested aeroallergens.   
IgE represent only the 0.004% of all immunoglobulin.  The total serum 
concentration differs in adults non atopic individuals, from 10 to 200 kU/l  
(1kU/l = 2.4 ng/ml); in infants the concentration is only a few kilo Units, and around 
10 years of age, it augments reaching adult’s levels. 
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An individual presents elevated total serum IgE when the IgE levels are superior of 
a determined relationship between age and IgE value, as seen in Table 3.1 
 
 
AGE IgE (kU/l) 
0 20 
1 50 
2 60 
3 85 
4 130 
5 130 
6 160 
7 160 
8 180 
9 180 
10 200 
 
 
Table 3.1  Threshold levels of IgE defined for age 
 
 
 
Individuals were defined atopic when in presence of elevated IgE levels and /or 
positive SPT. 
 
3.2  GENETIC ANALYSIS 
The genomic DNA analyzed, came from a sample of whole peripheric blood, 
previously purified with the standard technique of “salting out.” 
In brief, after the hemolisis through osmotic shock, the plasma membrane is lysed 
with the NONIDETP40 0.1% detergent.  The nuclei are lysed with SDS and are 
incubated at 37˚C with proteinase K for 12 hours or over night.  For the protein 
selective precipitation, a saturated solution of NaCl is added and the DNA is 
precipitated with absolute ethanol. 
The purity of the extracted DNA is calculated by the relationship between the 
absorbance at 260 nm and 280 nm. 
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3.3  SNP SELECTION 
SNPs, rs2031532, rs1046295, rs2247119, rs2274276, 185752b5_2, 185306b7_1, 
and 185752b4_2, located inside the PHF11 gene, previously associated with high 
IgE levels in Australian population (Zhang et al., 2003), were selected for the 
analysis.  The first four SNPs have been also associated to atopic dermatitis          
(Jang et al., 2005).  Figure 3.1 
All the subjects enrolled in this analysis were genotyped for the 7 selected SNPs. 
Moreover, for polymorphism validation analysis, 15 control samples from the local 
book bank, were analyzed. 
 
 
 
 
 
 
 
 
     1                                        2                          3                     4           5     6 7     8       9        10 
 
exon 
 
 
 
 
 
      
                                                           30 Kb 
 
 
Figure 3.1  PHF11 gene – polymorphisms analyzed in this study 
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3.4  POLYMORPHISMS’ VALIDATION 
Initially a set of 15 control samples, from the same population of the asthmatic 
families, were genotyped for the selected polymorphisms, to assess if the markers 
were polymorphic enough.  The methods applied to analyze allelic frequencies, 
and  the amplification conditions are summarized on Table 3.2.   
 
Table  3.2  Conditions utilized for the polymorphisms’ validation   
SNP / 
Markers 
Primer sequence 
Validation 
Method 
PCR 
T ann. 
(˚C) 
PCR 
Product 
rs2031532 
G/A  (2R_) 
F  AGACTGGAAGAGGAGTTAGTGA 
R  TGTGTCCAAAGTGTTGTTTATC 
Enzymatic 
Restriction 
RsaI /37˚C 
50˚C 279bp 
rs1046295 
G/A  (b5_3) 
F   TCATGCATCTCAACAAAGGT 
R  CAAGAGTGTGCAAAGAGTGAT 
Sequencing 52˚C 308bp 
185752b5_3 
G/A 
F  TCATGCATCTCAACAAAGGT 
R* CATGACTCTTGGCTTAGGAGA 
Enzymatic 
Restriction 
BsmAI /55˚C 
50˚C 169bp 
185752b5_2 
C/T 
F  TTCTAAGTTTCCACAATTAAAA 
R  AAGTCCCTTTGTATATCTTTGA 
Enzymatic 
restriction 
AluI /37˚C 
47˚C 218bp 
185752b4_2 
A/G 
F  CGTTTTTAATCACAAAAATAGACA 
R TCAAAGAGAATAGGTCTTGTTCAT 
Sequencing 48˚C 342bp 
185752b4_2 
A/G 
F* GGGTTTTAAAGAAAGGTAAACAAT 
R TCAAAGAGAATAGGTCTTGTTCAT 
Enzymatic 
Restriction 
MfeI /37˚C 
47˚C 187bp 
185306b7_1 
A/C 
F  GTCCTCAGTGTGACTCCCAGAG 
R  CAGTGCAGATGGATTAAAAACA 
Sequencing 53˚C 220bp 
rs2247119 
T/C 
F    TTAGGATAGGGGATCAGAC 
R    TTGTGCATACTCTGGATTT 
Enzymatic 
restriction 
Fnu4HI/ 37˚C 
55.2˚C 270bp 
rs2274276 
G/C 
F  TTCATCCTTATTAGTCTGTTTT 
R    ATCATAAGTGCTGCAAACA 
Enzymatic 
restriction 
NspI /37˚C 
46˚C 243bp 
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For the validation, the samples were amplified through PCR (Polymerase Chain 
Reaction).  The PCR products were incubated for 3 hours with 3U of Restriction 
Enzyme at the enzyme reaction conditions temperature.   
The genotypes of some samples to be used as positive controls were checked by 
sequencing (Figure 3.2 and 3.3).  After the PCR, the products were purified with 
Microspin HR Columns S-300, the purification was checked through the DNA 
Mass Ladder Dye on a 2% agarose gel.  The sequencing reaction was performed 
with the ABI PRISM Big Dye Terminator V1.1 Cycle sequencing Ready Reaction 
kit, after which each reaction was purified with the AutoSeq G-50 columns, and 
analyzed by the Automatic Sequencer ABI PRISM 310 (Applied Biosystems). 
 
 
Figure 3.2  Example of sequence of an homozygote individual 
 
 
Figure 3.3  Example of sequence of an heterozygote individual  
 
AA 
     TC 
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3.5  THE ddNTP PRIMER EXTENSION OR MINISEQUENCING TECNIQUE  
The ddNTP Primer Extension technique is based on the dideoxy single-base 
extension of an unlabeled oligonucleotide primer (or primers).  Each primer binds 
to a complementary template immediately before the SNP to be analyzed in the 
presence of fluorescently labelled ddNTPs and DNA Polymerase.  The 
polymerase extends the primer by only one nucleotide, adding a single ddNTP to 
its 3’ end. 
The ddNTP Primer Extension technique identifies a specific mutation without the 
sequence of the whole amplified product.   
 
 
3.6  THE ABI PRISM SNaPshot MULTIPLEX SYSTEM  
The ABI PRISM SNaPshot multiplex system is a ddNTP Primer Extension 
technique developed by Applied Biosystems for ABI PRISM Genetic Analyzer. 
The multiplex minisequencing protocol implicates five distinct steps: 
 
1. Polymerase Chain Reaction (PCR) - each SNP target-containing region is 
amplified using primers that flank it.  Different PCR product sizes for each 
selected SNP, are designed and optimized in a multiplex reaction. 
 
2. ExoSap Treatment - after inspection of the PCR product in an agarose gel, 
the amplicons are treated with exonuclease I (ExoI) and shrimp alkaline 
phosphatase (Sap) to eliminate primers and dNTPs. 
 
3. Minisequencing reaction – the technique is based on the annealing of a 
single probe adjacent to the polymorphic target site.  The probe is extended 
by a DNA polymerase in a cycle sequencing reaction with a fluorescently 
labelled dideoxynucleotide (ddNTPs).  The four different ddNTPs are 
labelled with different fluorescent markers, which can be detected by an 
automatic sequencer, allowing the identification of the incorporated 
ddNTPs.  The product size varies according to the probe size.  Tails of 
different size are added to each probe to allow the type resolution of several 
SNPs in the same reaction.   
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4. Sap Treatment –  the product is purified with Sap enzyme to remove 
unincorporated ddNTPs, that will co-migrate with the interested fragments. 
 
5. Electrophoresis on Genetic Analyzer – Minisequencing reaction products 
are separated by electrophoresis and analyzed on the ABI PRISM 310 
Genetic Analyzer with the Genescan analysis software. 
 
Figures 3.4 and 3.5 summarize the SNaPshot multiplex system reaction and 
procedure. 
 
 
 
The SNaPshot Multiplex Kit allows to multiplex up to 10 loci in one reaction.  It  
includes a Ready Reaction Mix, containing an AmpliTaq DNA Polymerase, 
fluorescently labelled ddNTPs, and a reaction Buffer.  
 
The fluorescent dyes are assigned to the individual ddNTPs as shown in the table  
below: 
 
 
ddNTP Dye Label Color of Analyzed Data 
A dR6G Green 
C dTAMRA Black 
G dR110 Blue 
T (U) dROX Red 
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     Probe 
 
Template 
 
   GGTTTTAAAGAAAGGTAAACATTT 
-NNNNNACTGTGGGTTTTAAAGAAAGGTAAACATTTGNNNNNNN 
 
            
         Interrogation target 
 
Ready Reaction mix: 
AmpliTaq DNA Polymerase, FS 
Reaction Buffer        Extend and  
ddGTP+ddCTP+ddUTP+ddATP     Terminate Probe 
 
 
 
               
           dd  
  GGTTTTAAAGAAAGGTAAACATTTC 
-NNNNNACTGTGGGTTTTAAAGAAAGGTAAACATTTGNNNNNNN- 
           
           
    Electrophoresis and 
          Analysis 
 
 
 
 
 
Florescence  
Intensity                                                               Genotype:  CC 
                                                   
                                             
Figure 3.4  Diagram of the Primer Extension Reaction 
 
 
 
____________________________________________________Materials and Methods 
 - 35 - 
 
 
 
 
SNP ANALYSIS PROCESS FLOW 
 
 
Amplify Target (by PCR) 
 
 
 
 
Purify PCR Products 
 
 
 
 
SNaPshot ddNTP Primer Extension Reaction 
 
 
 
 
Remove Unincorporated ddNTPs 
 
 
 
 
Electrophoresis and Genescan Analysis 
 
 
 
 
Figure 3.5  Single Base Extension reaction is performed after PCR amplification and post  
PCR clean up locus.  Specific primers anneals upstream of SNP and dideoxynucleotide is 
incorporated at the 3’ end with sequence specific terminator.  The resulting SNaPshot 
multiplex product contains a mobility modifier at the 5’ end.  Samples are post extension 
and separated on a capillary electrophoresis platform.  The resulting product is then 
differentiated by size and color.  The size is  a reflection of a locus specific mobility 
address while the color denotes the specific sequence context.  Using both tools allows 
high multiplexed SNP analysis. 
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The SNaPshot Multiplex kit includes also a Size Standard, which enables SNP 
length normalization and allows comparison of data set for inter- and intra-run 
comparison.  A Control Template containing an amplicon from CEPH DNA, and a 
Control Primer Mix with primers specific for 6 distinct SNPs are included in the kit 
to be used as positive control. ( Table 3.3). 
 
 
Multiplex Control 
Primer Mix 
Length of  
Final Product (nt) Signal color Heterozygosity 
20A  primer 21 Green Homozygote 
28G/A primer 29 Blue/green Heterozygote 
36G primer 37 Blue Homozygote 
44T primer 45 Red Homozygote 
52C/T primer 53 Black/red Heterozygote 
60C primer 61 Black Homozygote 
 
         Table 3.3  List of the six primers contained in the SNaPshot positive control and  
                           their characteristics.  
 
 
 
In Figure 3.6 is shown an example of electropherogram of a kit positive control  
Multiplex reaction. 
 
 
Figure 3.6 
 
 
    20A    28G/A                36G             44T          52C/T         60C 
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Each probe, for the minisequencing reaction, was designed following the 
SNaPshot probe recommendations:   
• difference of 4-6 nucleotides between probe lengths 
• temperature at least 50˚C 
• absence of hairpin structures 
• HPLC purification for probes longer than 30 nucleotides 
• Use of 5’ non-homologous tails with minimal secondary structures, such as 
poly (dA), poly (dGACT), poly (dC), and poly (dT).     
  
The probes were designed with OLIGO Primer Analysis Program. 
The melting temperature (Tm ), temperature in which the filaments of a double 
helix DNA are half dissociated, was calculated using the Wallace Role:  
4(G+C) + 2(A+T) (Thein and Wallace, 1986).   
For the technique set up, several control samples, with known genotype, coming 
from the SNP validation analysis, were used together with the positive control 
included in the kit.  The known genotypes allowed to observe the minisequencing 
reaction performance and the electropherogram quality, including the peaks’ size 
and florescence color. 
 
 
 
3.7  GENOTYPING ASSAY ANALYSIS 
The seven SNPs selected for the study were divided into three groups of analysis 
in order to resolve some setting up problems, such as different annealing 
temperature, and primer residue.  
Group A:  SNPs 185306b7_1 (A1), rs1046295 (A2)   
Group B:  SNPs rs2031532 (B1), 185752b4_2 (B2), 185752b5_2 (B3)   
Group C:  SNPs rs2247119 (C1) and rs2274276 (C2) 
Group A and B were analyzed through the ddNTP Primer Extension technique 
with the SNaPshot Multiplex Kit, while SNPs C1 and C2 were analyzed by single 
enzymatic restrictions.  
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In Table 3.4 are listed all the designed SNaPshot probes, HPLC purified and 
synthesized at 0.05µmol, tested for the technique. 
 
SNP SNaPshot probe sequence 
Name/ 
Strand 
Length  Tail Tm 
(T)9  AGATGTCGAATATAATGTCCT 2R-S1 
Positive 
30 9 T 56˚C 
rs2031532 
G/A (B1) (T)9 AAAGATGTCGAATATAATGTCCT 2R-S2 
Positive 
32 9T 60˚C 
ACATTGTATTCCTTATCAGATTAAAA 
(T)12 
b4-S1 
Negative 
38 12T 64˚C 
ACATTGTATTCCTTATCAGATTAAAA 
(T)14 
b4-S2 
Negative 
40 14T 64˚C 
185752b4_2 
A/G (B2) 
(GACT)4 
GGTTTTAAAGAAAGGTAAACATTT 
b4-S3 
Positive 
40 
12G 
ACT 
60˚C 
(T)21 
AGAAGAGCCGAAATCCATTAAGAC 
b7-S1 
Positive 
45 21T 68˚C 
GACACTATACCCCCCTAAATCGTC 
(T)21 
b7-S2 
Negative 
45 21T 72˚C 
185306b7_1 
A/C (A1) 
(GACT)8 
AAGAGCCGAAATCCATTAAGAC 
b7-S3 
Positive 
58 
8GA 
CT 
62˚C 
CCTGTCTTATTAGGGATTACC 
b5.3-S1 
Positive 
21 / 60˚C 
rs1046295 
G/A (A2) (ACT)1(GACT)7 
CCTGTCTTATTAGGGATTACC 
b5.3-S2 
Positive 
52 
7GA 
CT 
58˚C 
AAATACATTGTAATTTTTAACCTGTG 
TAAAAATC (T)19  
b5.2-S1 
Negative 
53 19T 82˚C 
(T)23 
CCTATTTCTAAATGAAACCAAAAGC 
b5.2-S2 
Positive 
48 23T 66˚C 
185752b5_2 
C/T (B3) 
AAATACATTGTAATTTTTAACCTG 
(T)24 
b5.2-S3 
Negative 
48 24T 58˚C 
  
Table 3.4    List of all the designed Oligo Probes utilized for the preparation of the  
                   minisequencing technique, and their characteristics.  
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The SNaPshot technique development involved various tests in which were 
introduced continuously changes to the procedure; several sets of primers, 
probes, and reaction conditions, were tested to obtain the optimal conditions. 
The preparation of a multiplex and a duplex PCR, with group B and A, 
respectively, was tested.   
 
 
3.8  ASTHMATIC SAMPLE ANALYSIS  
The following final protocol was used to genotype all the samples, belonging to the 
23 asthmatic families, enrolled in the study. 
The asthmatic samples were amplified through multiplex PCR.   
The five SNPs were analyzed into two groups, Mix A and Mix B, respectively.  In 
both protocols, 25ng of genomic DNA were used, with 0.55 Units of Taq DNA 
Polymerase (Platinum), 10x Buffer (50mM of KCl, 20mM Tris-HCl pH 8.4), 1.5mM 
of MgCl2, 0.2mM of each dNTP, H2O, and different primers’ quantities in a final 
volume of 30µl. 
In Table 3.5 are reported the PCR amplification conditions specific for Mix A and 
Mix B. 
 
                             PRIMERS 
PCR Mix 
Sequence quant. 
T ann. 
(˚C) 
PCR 
Product 
A1-F: GTCCTCAGTGTGACTCCCAGAG  
A1-R: CAGTGCAGATGGATTAAAAACA 
9pmoli 
15pmoli 
220bp 
MIX A 
A2-F: TCATGCATCTCAACAAAGGT 
A2-R: CAAGAGTGTGCAAAGAGTGAT 
9pmoli 
3pmoli 
53˚C 
309bp 
B1-F: AGACTGGAAGAGGAGTTAGTGA 
B1-R: CAAGAGTGTGCAAAGAGTGAT 
4pmoli 
9pmoli 
279bp 
B2-F: CGTTTTTAATCACAAAAATAGACA 
B2-R: TCAAAGAGAATAGGTCTTGTTCAT 
13pmoli 
8pmoli 
342bp MIX B 
B3-F: TTCTAAGTTTCCACAATTAAAA 
B3-R: CAAGAGTGTGCAAAGAGTGAT 
16pmoli 
11pmoli 
50˚C 
218bp 
 
Table 3.5 
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To eliminate non-specific PCR residue, it has been necessary to perform a 
touchdown PCR for both Mix A and B.  The following diagram illustrates the cycles 
and program used for the DNA amplification. 
 
MIX A 
1. 3 minutes of initial denaturation at 94˚C 
2. 20 cycles composed by: 
   30 seconds at 94˚C  
30 seconds at 60˚C with a touchdown of -0.5 ˚C at each cycle 
30 seconds at 72˚C 
3. 10 cycles composed by: 
30 seconds at 94˚C 
30 seconds at 53˚C (annealing temperature) 
30 seconds at 72˚C 
4. 2 minutes at 72˚C for final extension 
 
MIX B  
1. 3 minutes of initial denaturation at 94˚C 
2. 20 cycles composed by: 
30 seconds at 94˚C 
30 seconds at 60˚C with a touchdown of -0.5 ˚C at each cycle 
30 seconds at 72˚C 
3. 20 cycles composed by: 
  30 seconds at 94˚C 
  30 seconds at 50˚C (annealing temperature) 
  30 seconds at 72˚C 
4. 2 minutes at 72˚C for final extension  
 
 
After the PCR, the DNA was purified with SAP (Shrimp Alcaline Phosphatase) 
enzyme, which removes, from the dNTP, the phosphorous group in 5’; and ExoI 
(Exonuclease I ) enzyme, which removes primer’s residue.  The purification is 
needed to eliminate unincorporated primers and dNTP before the SNaPshot 
reaction takes place.  For the purification, 5 Units of SAP and 2 Units of ExoI 
enzymes were added to 15 µl of PCR product.  These, were incubated for 1 hour 
at 37˚C, followed by 15 minutes at 75˚C to inactivate the enzymes. 
A GeneAmp PCR System 9700 was used for PCR and products purification. 
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The minisequencing reaction for the samples was prepared as shown on table 3.6 
 
 
                         ITEM 
 
VOLUME 
(µl/ sample) 
 
SNaPshot Multiplex Ready Reaction Mix 5 
Pooled PCR Products 2 
Pooled SNaPshot primers 2 (0.5-1µM) 
Deionized water 1 
Total  µl 10 
            
              Table 3.6  Sample SNaPshot reaction mix 
 
 
A positive and a negative control, with known fragments and probes, were added 
in each reaction. 
The Pooled SNaPshot primer solution were composed by a mixture of all the five 
designed primers, while the Pooled PCR products were composed by a mixture of 
PCR with Mix A and PCR with Mix B.  The specific quantities used for the two 
mixture are reported on Table 3.7  
 
 
 
   Mix A   PCR Products 
Total 2µl 
 
   Mix B  
1 µl 
B7-S3 (A1) 1.2µM 
B5.3-S2 (A2) 0.6µM 
2R-S2 (B1) 1.3µM 
B4-S3 (B2) 1.2µM 
SNaPshot Designed Primers 
Total 2µl 
B5.2-S2 (B3)  2  µM 
   
              Table 3.7  Quantities used in the SNaPshot reaction mix 
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The thermal cycler program applied to the minisequencing reaction was:   
25 cycles composed by 10 seconds at 96˚C 
      5 seconds at 50˚C 
    30 seconds at 60˚C 
 
After the SNaPshot reaction, the samples were purified with 1-2 Units of  SAP 
enzyme for 1 hour at 37˚C, and 15 minutes at 75˚C.  A second purification 
prohibits the unincorporated ddNTPs to co-migrate with the fragments of interest 
causing interference. 
 
 
 
3.9  CAPILLARY ELECTROPHORESIS ON ABI PRISM 310 
The reaction products minisequencing analysis was performed on ABI PRISM 310 
Genetic Analyzer, which separates the DNA fragments by size through capillary 
electrophoresis, a movement of charged molecules through a polymer in an 
electrical field. 
 
 
 
Figure 3.7  ABI PRISM 310 Genetic Analyzer (Applied Biosystems) 
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During the analysis, the sample tubes are placed in a tray in the instrument’s 
autosampler.  The autosampler brings each sample successively into contact with  
the cathode electrode and one end of a glass capillary filled with polymer.  An 
anode electrode at the other end of the capillary is immersed in buffer.  A portion 
of the sample enters the capillary as current flows from the cathode to the anode. 
This is called electrokinetic injection.  The end of the capillary near the cathode is 
then placed in buffer.  Current is applied again to continue electrophoresis.  When 
the DNA fragments reach the detector window in the capillary coating, a laser 
excites the fluorescent dye labels.  Emitted fluorescence from the dyes is collected 
by a CCD camera.  A matrix corrects the spectral overlap between colors on the 
CCD array.  The software interprets the result, calculating the size of the 
fragments from the fluorescence intensity at each data point. 
The ABI PRISM 310 can read up to five different wavelengths, allowing the 
labelling of the four dNTPs and of a GeneScan -120 LIZ size standard, specifically 
designed for short fragments (Figure 3.8). 
 
 
 
 
 
 
 
Figure 3.8  Elecropherogram of the GeneScan 120 Liz Size Standard 
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After the purification, the minisequencing products were prepared for capillary 
electrophoresis.  To each tube were added 1.5µl of SNaPshot reaction product, 
1.5µl of 1:2 LIZ size standard, and 12µl of Hi-Di formamide, for a total injection 
volume of 15µl.  The samples were denatured for 5 minutes at 95˚C, and put on 
ice until ready to be loaded on the genetic analyzer.   
The polymer used for the sample analysis was “POP-6 Polymer” in conjunction 
with “GS POP-4 (1mL) E5” module. 
 
On Table 3.8 are summarized all the parameters encoded for the E5 Run Module. 
 
Parameter 
  Control Module 
GS POP-4 (1mL) E5 
Injection time 5 seconds 
Electrophoresis voltage 15 kV 
Collection time 24 minutes 
EP Voltage 15 kV 
Heat plate temperature 60˚C 
Syringe pump time 150 seconds 
Preinjection EP 120 seconds 
          Table 3.8 
 
The run time was shorten to 18-20 minutes, which was found to be enough to 
obtain the appearance of all the interested peaks.  
 
 
 
3.10  MIX C SNP ANALYSIS 
Differently from Mix A and B, Mix C SNPs, rs2247119 and rs2274276, were 
amplified singularly through PCR (see Table 3.2 for primers, and PCR products), 
and analyzed with enzymatic restriction, since it was difficult to find common PCR 
conditions with the other SNPs. 
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Table 3.9 briefly summarizes the PCR and enzymatic restriction conditions use for  
Mix C SNP analysis. 
 
 
 
3’ at 94˚C 
35cycles of: 
30s at 94˚C 
30s at 55.2˚C 
30s at 72˚C 
rs2247119 
(C1) 
2’ at 72˚C 
 
Fnu4 HI 
(3U) 
 
 
3’ at 94˚C 
35cycles of: 
30s at 94˚C 
30s at 46˚C 
30s at 72˚C 
rs2274276 
(C2) 
     PCR 
2’ at 72˚C 
Enzymatic 
Restriction 
at 37˚C 
for 3 hours 
Nsp I (3U) 
 
 
        
       Table 3.9 
 
 
In both PCR protocols, 200ng of genomic DNA were used, with 0.50 Units of Taq 
DNA Polymerase (Platinum), 10x Buffer (50mM of KCl, 20mM Tris-HCl pH 8.4), 
1.25mM of MgCl2, 0.2mM of each dNTP, H2O, 15pmoli of primers, in a final 
volume of 30µl. 
The PCR products were, then, incubated for 3 hours at 37˚C with 3 Units of the 
appropriate restriction enzyme. 
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3.11 STATISTICAL ANALYSIS 
 
The statistical analysis of asthma and of all complexes diseases, is based on non 
parametric linkage analysis.  The use of non parametric analysis is necessary, 
since there aren’t any indications on the diseases’ transmission method, on the 
number of involved genes, and on allelic frequencies. 
Allele and genotype frequencies for each SNP were determined.  The Hardy-
Weinberg equilibrium was calculated.  Genotyping data were analyzed by the TDT 
Test.  This test compares the frequency with which a particular allele is transmitted 
from each parent to the affected child, with the frequency with which the allele is 
not transmitted.  The test is performed on families with one or more affected child, 
in which one of the parents is heterozygote for the questioning allele.  It is not 
important if the parent is affected or not.  The estimation is completed on the all 
family progeny, in the entire sample families analyzed.  Then, the chi-square test 
is used to observe if the difference between the two frequencies is significant.  
When both of the parents are homozygote or heterozygote, the family is eliminated 
from the calculation ( Hoffjan, 2003). 
The program used for the analysis is the UNPHASED Software (by Frank 
Dudbridge), available on the website:   
http://www-bsu.cam.ae.uk/personal/frank/software/unphased  
The haplotypes analysis was performed with the same program. 
The advantages of this analysis method compared to the association study on the 
general population, is that, it reduces the risk of mistaken associations caused by 
population evolution and incorrect discovery.   
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4.  RESULTS 
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4.1  SNP ANALYZED 
The SNPs selected for the analysis, were previously reported in literature (Zhang 
et al., 2003;  Jang et al., 2005) to be associated to elevated IgE levels and atopic 
dermatitis.  The seven SNPs analyzed were:  rs2031532, in exon 2; rs1046295, in 
the 3’ UTR zone; rs2247119, in intron 3; rs2274276, in intron 4; 185752b5_2, in 
intron 9; 185306b7_1, in intron 1; and 185752b4_2, in intron 5. 
 
4.2  POLYMORPHISM VALIDATION 
A polymorphism validation analysis was performed in a set of 15 control samples 
from the analyzed population through sequencing and enzymatic restrictions (see 
Table 3.2 in Material and Methods).  The SNP genotype frequencies of the 
validation analysis are summarized on Table 4.1 
 
 
            SNP 
 
Validation Allelic  
Frequencies 
          (%) 
rs2031532 G/A (B1) G = 67 
A = 33 
185752b4_2 A/G (B2) A = 50 
G = 50 
185752b5_2 C/T (B3) C = 53 
T = 47 
185306b7_1 A/C (A1) A = 33 
C = 67 
rs1046295 G/A (A2) G = 40 
A = 60 
rs2247119 T/C (C1)  T = 22 
C = 78 
rs2274276 G/C (C2)  G = 42 
C = 58 
 
Table 4.1  Allelic Frequencies of the validation analysis 
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All the selected SNPs, after the validation analysis, resulted polymorphic, 
therefore, they were chosen to be analyzed in the population object of this study. 
 
 
4.3  ANALYSIS SETUP RESULTS 
The multiplex (triplex and duplex) PCR required various tests for a correct 
amplification product, since the selection of an annealing temperature that worked 
for all the sets of primers, was difficult to obtain.  Also, the presence of non-
specific fragments brought several obstacles to both PCR assembly. 
After PCR preparation, the designed oligo probes, such as b5.2-S1, b5.3-S1, b7-
S1, b7-S2, 2R-S1, b4-S1, summarized on Table 3.4 in Materials and Methods, 
were used in the SNaPshot minisequencing reaction.   
At first, the peaks, resulted from the reaction, were anomalous.  They were joined 
together at the same position as shown in Figures 4.1 and 4.2. 
 
 
 
 
 Figure 4.1 and 4.2  Anomalous peaks of the SNaPshot reaction  
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To improve the peaks, several tests with diverse reagents quantities, duplex and 
triplex PCR, separated and then united just before the SNaPshot reaction, were 
tested.  At this point, the peaks improved, but still presented some irregularities in 
their position.   (Figure 4.3 and 4.4).   
 
 
 
 
  Figure 4.3 and 4.4  Electropherograms still presenting some irregularities.  
 
 
 
Following these second series of tests, the probes were run on a 40% acrylamide 
gel to check their purification.  This analysis showed that the probes were not 
synthesized properly as seen in Figure 4.5. 
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Figure 4.5  Acrylamide gel showing the probes purity.  As seen on the gel, only probes 7,  
       8, and 9, were synthesized properly.  
 
 
Then, a second set of probes, with different characteristics, was designed:  b5.2-
S2, b5.2-S3, b5.3-S2, b7-S3, 2R-S2, b4-S2.  Several new tests were carried out 
with the new probes.  The tests completed, first with single PCR, then with duplex 
and triplex PCR together, presented new electropherograms.  The peaks were 
normal and in the correct nucleotide position, except for the probe b4-S2 peak, 
which failed to amplify.  (Figure 4.6 and 4.7) 
 
 
 
Figure 4.6 and 4.7  Electropherogram peaks of the new designed probes, probe b4-S2 is  
         not showing. 
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Further tests were completed with probe b4-S2, but the problem with it persisted.  
The resulted genotype, in fact, did not correspond to the genotype obtained from 
the polymorphism validation.  Therefore, a third probe for marker 185752b4_2 (b4-
S3) was designed with a poly dGACT tail. 
Various SNaPshot reaction, with diverse PCR and probe quantities, were carried 
out with the new synthesized b4-S3 probe; the obtained new peaks matched the 
genotype seen in the previous analysis. (Figure 4.8) 
 
 
 
 
Figure 4.8  Final electropherogram peaks resulted from the preparation of the Primer  
        Extension Technique.  
 
 
 
The final probes used in the SNaPshot reaction to genotype all the asthmatic 
families, are summarized on Table 4.2.  
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          SNP                     PROBE SEQUENCE 
LENGTH 
    (nt)   TAIL  
2R-S2     G/A 
rs2031532 (B1) (T)9 AAAGATGTCGAATATAATGTCCT 32 9T 
b4-S3     A/G 
185752b4_2 (B2) (GACT)4 GGTTTTAAAGAAAGGTAAACATTT 40 12GACT 
b7-S3     A/C 
185306b7_1 (A1) (GACT)8 AAGAGCCGAAATCCATTAAGAC 58 8GACT 
b5.3-S2   G/A 
rs1046295  (A2) 
(ACT)1(GACT)7 
CCTGTCTTATTAGGGATTACC 
52 7GACT 
b5.2-S2   C/T 
185752B5_2  
(B3) 
(T)23 CCTATTTCTAAATGAAACCAAAAGC 48 23T 
 
Table 4.2  Summary of final probes used for the analysis of the asthmatic families 
 
 
 
7 SNPs, located on an overall area of 30 Kb, were amplified through PCR:  SNPs 
rs2031532 (B1), 185752b4_2 (B2), and 185752b5_2 (B3), with a triplex PCR; 
SNPs rs1046295 (A2), and 185306b7_1 (A1) with a duplex PCR.  5 SNPs were  
analyzed simultaneously with the SNaPshot ready reaction mix kit (Applied 
Biosystems) on the ABI PRISM 310 Genetic Analyzer, and the SNPs rs2247119 
(C1) and rs2274276 (C2), were analyzed by PCR, and restriction analysis.  
(see Table 4.3) 
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GROUPS SNP PCR 
 
ANALYSIS METHOD 
 
rs2031532 (B1) 
185752b4_2 (B2) GROUP A 
185752b5_2 (B3) 
Triplex 
185306b7_1 (A1) 
GROUP B 
rs1046295 (A2) Duplex 
ddNTP Primer Extension Technique 
rs2247119 (C1) 
GROUP C 
rs2274276 (C2) Single Single Enzymatic Restriction 
 
       Table 4.3  Summary of the analysis performed in the study 
 
 
 
4.4  ASTHMATIC FAMILIES ANALYSIS 
In this study, 23 families with at least one affected child, have been analyzed.  The 
selected families showed positive linkage to elevated total serum IgE.  The 
characterization of 7 SNPs, located on the PHF11 gene, have been completed 
through the development of an efficient multiple genotyping method, based on the 
ddNTP Primer Extension technique 
 
 
4.5  MINISEQUENCING ANALYSIS RESULTS 
The results obtained from the analysis performed in this study are following.   
In Figure 4.9 is illustrated the image of the triplex PCR products completed on 
asthmatic individuals analyzed for SNPs rs2031532 (B1), 185752b4_2 (B2), and 
185752b5_2 (B3) at 50°C annealing temperature.  The electrophoresis was 
completed on a 2% agarose gel, and the PCR amplified fragments are 342bp (B2), 
279bp (B1), and 218 bp (B3). 
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         1      2     3      4     5      6     7    8     9    10    11   12    13   14    15   16 
 
           1Kb    17    18   19    20    21   22   23   24    25 
 
      Figure 4.9   Amplification of SNPs 185752b4_2, rs2031532, and 185752b5_2 at 50°C  
               annealing temperature. 
 
 
 
 
In Figure 4.10 is illustrated the image of the duplex PCR products completed for 
SNPs rs1046295 (A2), and 185306b7_1 (A1) at 53°C annealing temperature.  The 
electrophoresis was completed on a 2% agarose gel, and the amplified PCR 
fragments are 309 bp (A2), and 220 bp (A1).   
 
 
 
 
 
 
 
 342bp   185752b4_2 
 279bp  rs2031532 
 218bp  185752b5_2 
1kb Mass Ladder 
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          Figure 4.10   Image of the duplex PCR for SNPs rs1046295, and 185306b7_1  
                       on a 2% agarose gel at 53°C annealing temperature 
 
 
The triplex and duplex PCR products, after purification with SAP and ExoI 
enzymes, were joined together to undergo a single SNaPshot reaction using the 
probes listed on Table 4.2.  In Figures 4.11, 4.12, 4.13, 4.14, 4.15, 4.16, and 4.17  
are illustrated the elecropherograms of the asthmatic families analyzed for SNPs 
A1, A2, B1, B2, B3, respectively located at 58, 52, 32, 40, and 48 nucleotides, with 
the corresponding genotype. 
 
 
GA       GA           CT      GA         AA 
Figure 4.11  Family 2 individual’s electropherogram of the 5 analyzed SNPs.  The figure  
                     illustrates the nucleotide position and the genotype.    
 309 bp rs1046295 
 220 bp 185306b7_1 
 40 
 32 
 48 
 52 
 58 
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       GA          AA       CC             GG        AA 
Figure 4.12  Family 63 individual’s electropherogram of the 5 analyzed SNPs.   
 
 
 
 GA       GA   CT         GA   AA 
Figure 4.13  Family 51 individual’s electropherogram of the 5 analyzed SNPs with the  
         corresponding genotype. 
 
 
 
         AA      AA         CC      GG   AA 
Figure 4.14  Family 105 individual’s electropherogram  
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         GA        GA             CT      GA     CA 
     Figure 4.15  Family 65 individual’s electropherogram  
 
 
 
GA            GA     CT           GA     AA 
    Figure 4.16  Family 106 individual’s electropherogram 
 
 
 
         AA      AA        CC       GG                 AA 
    Figure 4.17  Family 79 individual’s electropherogram 
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4.6  RESTRICTION ENZYME ANALYSIS RESULTS 
 
SNPs C1 and C2 were analyzed through single PCR and Enzymatic Restriction.  
Beneath, are reported the two sequences for SNPs rs2247119 and rs2274276, 
with their forward and reverse primers in orange, and the point of the restriction 
site is market in green. 
 
 
ATTGCTCAAAGCCCATTCCACACTTTTAGGATAGGGGATCAGACTGACCCAGCTTGGCATCAG
GGTTCCACCCAGGTCAATGAGTTATTAGAGGTCAGGATTACAAAGTATAAAACATGCCCGGAA
ACCAGGGTCATTCCCAGAGAAATGGGATGGCTTATGGTCTGCTCATCCACCCCCAAAGTTGCA 
CTGTTTTACCCCCAGTCCATTTCCCACTCCTGGTTTGATTTTCCACTTTTGGTATGATTTTCTGA
CATGT/C AGCTTTCAATATTACTTTGTGCATACTCTGGATTTTTTTTTCCAATCTGCAGCTGTAT 
CTTCAGGACTTGTGGAATGTGAGGATCAGGATCCACTTAATCCTGATAGAAGTTTTGATGTGG
AATCAGTAAAGAAAGAAATCCA 
 
Figure 4.18  Sequence of SNP rs2247119.  In orange are highlighted the forward and  
reverse primers, as well as the analyzed allele.  The enzyme used in the 
restriction was Fnu4 HI.  
 
 
 
 
TACAGATACTTCTTTAAATCAGTGTTTATTGACAGGGAAAAGCACCAGCAATACACACTTAACC 
AAATCCTTGCAAATGTCATCTATTAAATATCTTCATCCTTATTAGTCTGTTTTACTTTGAATATCT
TCTGAGTGAAATTGAGTGCATTCCCATATCTTTTCACCAATTATATTTGTTTTCCTATGACCCAA
TTTGTTCATTTTTCTATTCAATGAACCCTCTCCCCAGAGAGTTCCG/CCATG TGCCAATTTTTCT 
ACTCAATTATTTACCTGTTTTGCATTAAACTTATAATATCTTTTTTAAAAATTAACCCTTTATCATA 
AGTGCTGCAAACACTTAGTTGAAGTTTGCCATATCTTTTGACTTTGTAAAAACTTTTGGCATATG
AGTTGTATATTTCATGTAGTCAAACAGTAAT 
 
Figure 4.19  Sequence of SNP rs2274276.  In orange are highlighted the forward and  
reverse primers, as also the analyzed allele.  The enzyme used in the 
restriction was Nsp I. 
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        Figure 4.20   
 
 
In Figure 4.20 is illustrated the image of the PCR products for SNP rs2247119 
performed on all the asthmatic patients.  The electrophoresis was completed on a 
2% agarose gel, and the amplification fragment was 270 bp long. 
 
 
 
 
Figures 4.21 and 4.22  illustrate rs2247119 T/C enzymatic restriction with Fnu4 HI 
enzyme, performed after PCR.  The electrophoresis was completed on a 3.5% 
agarose gel.  In lines 1, 2, 3, 4, are shown the normal homozygote patients 
eletrophoresis patterns (fragment 270bp); lines 5 and 6 show the affected 
homozygote patterns; and lines 7, 8, 9, and 10 show the heterozygote patterns 
(fragments 270bp and 235bp).  In line 11, the 1kb molecular weight marker 
pattern, is present. 
 
 
 
 
     270 bp 
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          1    2   3         4         11 
 
               Figure 4.21   
 
           7   8    9  10        11 
 
              Figure 4.22 
 
 
 
Figures 4.23 Illustrates a single PCR of SNP rs2274276  performed on all the 
asthmatic patients.  The electrophoresis was completed on a 2% agarose gel, and 
the amplification fragment was 243 bp long. 
 
 
 
  5    6 
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               Figure 4.23 
 
 
 
Figure 4.24 and Figure 4.25  illustrate rs2274276 G/C enzymatic restriction with 
Nsp I enzyme, performed after PCR.  The electrophoresis was completed on a 
3.5% agarose gel.  In lines 1, 2, 3, 4, are shown the affected homozygote patients 
eletrophoresis patterns (fragment 150 bp and 93 bp); lines 5, 6 and 7, show the 
normal homozygote patterns; and lines 8, 9, and 10 show the heterozygote 
patterns (fragments 243 bp, 150 bp, 93 bp).  
 
                     1   2     3    4 
 
          Figure 4.24                      5 
  
         
  243 bp 
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Figure 4.25              8   9   10 
 
 
4.7  STATISTICS 
Genotyping data were collected in a database and sent to the math laboratory for 
statistical analysis.  Allele and genotype frequencies were calculated and the 
Hardy-Weinberg equilibrium was tested. 
The allelic frequencies, calculated for the 46 founders of the analyzed population, 
are reported on Table 4.4.   
 
SNP ALLELE FREQUENCY 
G 37 % 
rs2031532 G/A (B1) 
A 63 % 
A 46 % 185752b4_2 A/G (B2) 
G 54 % 
C 39 % 185752b5_2 C/T (B3) 
T 61 % 
A 41 % 185306b7_1 A/C (A1) 
C 59 % 
G 52 % 
rs1046295 G/A (A2) 
A 48 % 
T 30 % 
rs2247119 T/C (C1)  
C 70 % 
G 46 % 
rs2274276 G/C (C2)  
C 54 % 
         Table 4.4 
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A non-parametric linkage analysis was completed for asthma, atopy, BHR, IgE, 
Rhinitis, and SPT phenotypes, using the Merlin program.  The analysis results 
provided the p-value and the logarithm of odds (LOD).  The results are reported on 
Table 4.5.  As seen on the table, a significant p-value was observed only for atopy 
and IgE phenotypes, confirming previous finding of the presence of linkage with 
IgE for 13q14 region. 
 
 
 
PHENOTYPE 
 
LOD 
 
p-value 
Asthma 0.1 0.2 
Atopy 2.03 0.001 
BHR 0 0.6 
IgE 1.78 0.002 
Rhinitis 0.36 not significant 
SPT 1.01 0.02 
 
Table 4.5  The table illustrates the non-parametric linkage analysis results attained with  
      the Merlin program in the asthma population sample (144 individuals) with the         
      polymorphisms used.  The LOD is the logarithm of odds; a LOD value equal or  
      bigger than 3, indicates a linkage between the marker and the locus.  A p-value  
      equal or smaller than 0.05 indicates that the results are significant.  These    
      values were still significant after correction for multiple testing. 
 
 
 
 
Subsequently, it was completed a qualitative association analysis with all the 
collected phenotypes and the analyzed SNPs through the TDT test.  The analysis 
was performed on all the offspring (affected children 49 for asthma, 74 for atopy, 
47 for BHR, 63 for IgE, 45 for rhinitis, and 66 for SPT) together for all the 7 
markers analyzed.  Then, it was carried out only on female offspring for all the 7 
markers, and after only on male offspring for the 7 markers.  The results of the 
qualitative association analyses are reported on Table 4.6   
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                                    STATISTICAL ANALYSIS:  TDT TEST 
 
PHENOTYPE 
All 7 markers 
All offspring 
all 7 markers 
female offspring 
all 7 markers 
male offspring 
Asthma not significant not significant 0.02 p-value marker 5 
Atopy not significant not significant not significant 
BHR not significant not significant not significant 
Dust mites not significant not significant not significant 
IgE 0.09 p-value marker 5  0.07 p-value marker 5 not significant 
Rhinitis not significant not significant 0.03 p-value marker 5 
SPT not significant not significant not significant 
 
 
Table 4.6  Illustration of the results obtained from the TDT analysis.  As seen on the       
table, IgE showed a 0.09 p-value on marker 5 for all offspring, a 0.07 p-value 
on marker 5 for female offspring.  Asthma showed a 0.02 p-value on marker 5 
for male offspring, and rhinitis  showed a 0.03 p-value for male offspring.  
These values were not significant after correction for multiple testing. 
 
 
 
 
Then, a qualitative analysis was completed on the haplotypes for all the 7 
analyzed markers, with no significant data.   
The analysis was also extended on all the markers for the 4 most common 
haplotypes (with a population frequency higher than 2%) on female offspring; 
reporting a 0.07 p-value for atopy, a 0.05 p-value for dust mites, and a 0.07 p-
value for SPT.  These values were not significant after correction for multiple 
testing. 
 
A quantitative Ig analysis of the genotyped families did not show any significant 
association for single SNP or 7 markers haplotype analysis.  
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5. DISCUSSION 
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5.1  RESULTS HYPOTHESIS 
Asthma is a multifactorial disease attributed to environment and multiple 
interacting genes, each contributing in the disease development, and having its 
own variable tendency to be expressed. 
Asthma can be caused by an environmental allergen sensitization. Its interaction 
with the innate immune system, its uptake by antigen-presenting cells, and the 
subsequent T cell priming, leads to the stimulation of cytokines such as IL-4, IL-5, 
and IL-13.  These cytokines interact with their receptors to stimulate IgE 
production and increase the numbers of eosinophils and mast cells, triggering 
inflammation in the respiratory tract.   
Significant progress has been made in the field of asthma genetics in the past 
decade.  Investigators have been studying the disease and its complexity, but still 
now it has been difficult to clearly determine the roles of the genes and the trigger 
factors associated with the disease expression.   
Eleven full genomic screens reported chromosomes 1p, 2q, 3q, 4q, 5q, 6p, 7q, 
11q, 12q, 13q, 14q, 15q, 17q, 19q, and 21q, to be associated to asthma and its 
phenotypes (Hoffjan et al., 2002). 
Since our previous linkage of region 13q14 to total serum IgE levels and asthma; it 
was decided to further investigate this region in asthmatic patients from north east 
Italy. 
Cookson reported in literature (Zhang et al, 2003) a positive linkage of region 
13q14 to total serum IgE and related phenotypes.  In the study, Cookson found 3 
SNPs, rs1046295, in the 3’ UTR zone; 185752b5_2, in intron 9, and 185752b4_2 
in intron 5 (through TDT program analysis) of the PHF11 gene to have an 
independent effect in the preferential transmission of the allele associated to 
elevated IgE  (rs1046295 with a 0.05 p-value; 185752b5_2 with a 0.0004 p-value; 
and 185752b4_2 with a 0.008 p-value). 
In this study, the development of a multiple genotyping technique in a group of 
Italian asthmatic families, was set up and then used for the analysis of 5 SNPs (2 
analyzed by enzymatic restriction) located on the PHF11 gene, in region 13q14. 
The results of this study confirmed the presence of linkage with elevated total 
serum IgE levels in the region.  The data observed from the analysis carried out 
with the Merlin program, showed significant associated p-values with atopy (0.001) 
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and elevated IgE (0.002) phenotypes.  This indicates that the 13q14 region, as 
confirmed by the study of Cookson, is linked to total serum IgE levels, suggesting 
the possibility of the presence of a positive correlation.   
On the other hand, the results obtained from the TDT analysis did not confirm 
association to asthma, as observed in the study of Cookson.  Most likely this is 
because in the present study only 7 markers were analyzed, and perhaps it is 
necessary to analyze a wider number of markers in the PHF11 gene, extending 
the analysis in the neighbouring upstream and downstream genes, such as 
SETDB2 and RCBTB1.  Also the number of the analyzed families was very small, 
even if they were selected for the presence of linkage, but in a bigger number of 
individuals, it would be simpler to find association.  In fact, usually in wider 
analysis there is a larger probability to find positive and certain data.   
Additionally, the association in the population, analyzed in this work, may possibly 
be altered by the presence of other polymorphisms in the PHF11 gene or in 
neighbouring genes, which may have had a small or modest effect on the 
analyzed disease.  In fact, it has been observed in literature that consistency in 
replicated studies is difficult (Hakonarson et al., 2001).  This suggests that there 
may be a wide range of variability in the allelic frequencies of these genes, and 
that the studied loci possibly could represent a false-negative/positive association 
or linkage.   
It is important also to mention that environmental and lifestyle factors play a major 
role in atopy and asthma.  Recent studies have discussed the so-called hygiene 
hypothesis, which states that the lack of intense infections in industrialized 
countries owing to improve hygiene, vaccination, and use of antibiotics may alter 
the human immune system such that it responds inappropriately to innocuous 
substances (Martinez, 2001).  Besides, early life infections, which are considered 
negative, may instead have a protective effect on a later development of allergies. 
In Germany, it was seen that children from Leipzig have an inferior and less 
common incidence of asthma, than children from Munich, suggesting that atopy 
and asthma are more common in westernized countries (von Mutius et al., 1992).  
Also, studies performed on farmers’ children found that growing up on a farm 
confers significant protection against the development of atopy, allergic rhinitis,  
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and asthma (Von Ehrenstein et al., 2000; Braun-Fahrlander et al., 1999; Riedler et 
al., 2000; Ernst et al., 2000).  This indicates that substances produced by farm 
animals, could play a role in the prevention of allergies.   
The development of asthma could be possibly affected by the different lifestyles 
and the environmental factors that these people have experience during their 
childhood and later life.    
Therefore, it is difficult to define a specific reason why in the present study the 
linkage with elevated total serum IgE, but not the association with the disease, 
was confirmed, since many factors could have had considerable importance.  
 
 
 
5.2  THE ANALYSIS TECHNIQUE 
The ddNTP Primer Extension technique was selected for the SNP investigation 
employed in the study, to test its efficiency and accuracy for future studies.  The 
technique turned out to be very efficient in the analysis after the setting up 
procedure. In this study only 5 SNPs where analyzed with the technique and 2 
with enzymatic restriction; definitely I suggest to analyzed more SNPs by 
minisequncing, the SNaPshot Multiple Reaction Kit can analyze up to 10 SNPs 
simultaneously.  The disadvantages of the technique could be represented by 
procedure setting up.  Finding the best condition for the multiplex PCR and 
minisequencing reactions require a lot of time and are a little expensive.  But, once 
the best conditions are obtained, it is possible to test a large number of samples in 
a short period of time in an automatic way.   
Overall, the ddNTP Primer Extension technique is an excellent method for large 
populations multiple SNP analysis.  Moreover, in large investigations the costs will 
be amortized by the SNPs’ number and samples analyzed.  
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5.3  CONCLUSION 
In conclusion, 7 SNPs on the PHF11 gene, region 13q14, were analyzed in this 
study.  The results, differently from what reported in literature, did not confirm 
association of elevated total serum IgE to asthma, but confirmed the presence of 
linkage with region 13q14. 
The analysis suggests that other polymorphisms or genes may be involved, and 
can interfere with the association, as well as lifestyle and environmental factors 
may have considerable importance.  
It may be appropriate to further extend the sample size and the analyzed region to 
other neighbouring regions. 
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